Latest Content

Timothy Aungst, PharmD; Ravi Patel, PharmD, MBA, MS; and Smit Patel, PharmD; provided much-needed nuance to the evolving nature of DTP pharmacy models in today’s landscape.

Phase 3 OCEANIC-STROKE shows asundexian cuts recurrent ischemic stroke by 26% on top of antiplatelets, without more major bleeding.

In what reports are calling a landmark settlement, Cigna agrees to make good on years of unfair business dealings that have affected patients and independent pharmacies.

Exploring the perspectives of health care professionals, researchers test the feasibility of the Asthma Care from Home project.

Pharmacists guide smokers in choosing effective OTC cessation aids, enhancing success rates with tailored nicotine replacement therapies for cravings and withdrawal relief.

Real-world data shows empagliflozin cuts mortality in broader type 2 diabetes patients, supporting wider sodium-glucose co-transporter 2 inhibitor use with careful safety monitoring.

This episode explores the “uphill climb” that many leaders in the modern pharmacy landscape experience and how experts like our hosts are navigating this challenge.

Phase 3 data show oral fenebrutinib slows primary progressive multiple sclerosis disability progression versus ocrelizumab, with early upper-limb gains and a manageable safety profile.

Timothy Aungst, PharmD; Ravi Patel, PharmD, MBA, MS; and Smit Patel, PharmD, share their insights on the emerging direct-to-patient pharmacy model.

Pharmacists play an important role in guiding safe and effective OTC pain management, ensuring optimal patient care and minimizing risks.

CDC updates vaccination guidelines, emphasizing individual choice for COVID-19 and standalone chickenpox shots, while addressing vaccine hesitancy and misinformation.

TrumpRx drives Most-Favored-Nation drug pricing, cutting US costs for glucagon-like peptide-1, insulin, and fertility medications.

Anne Cassity, senior vice president of government affairs at NCPA, discusses the next moves of both PBMs and community pharmacy advocates following the signing of HR 7148.

As provisions begin rolling out over the next few years, community pharmacies will no longer be at the will of unfair reimbursement and contracting terms.

Pharmacists push for provider status and PBM overhaul as IRA policies squeeze pharmacies—what it means for access to vaccines, PrEP, and vital meds.

Pharmacists evolve from ancient healers to vital health care providers, enhancing patient care and accessibility in today's strained health system.

With President Trump’s signing of HR 7148, experts are now racing to get a grasp on the monumental shifts in pharmacy that will stem from this new legislation.

Pfizer's phase 2b study reveals promising results for its monthly GLP-1 therapy, enhancing weight loss and medication adherence in obesity management.

IBSA’s formulation of sildenafil, known as Vybrique, will hit the market in March 2026 as the first and only oral film that treats erectile dysfunction.

With infectious disease rates expected to jump as US vaccine schedules are reworked, antimicrobial stewardship programs are seeking community pharmacists.

John C. Goodman explores TrumpRx's initiatives to lower prescription drug prices, emphasizing direct-to-consumer purchasing and innovative employer strategies for savings.

Novo Nordisk's CagriSema shows significant improvements in blood glucose control and weight loss for type 2 diabetes patients in recent trial results.

Episode 7 dives into new standards of care from the American Diabetes Association and what updates are most important for pharmacists.

Through the perspectives of US health care plans and payers, researchers explore the differences in cost between single maintenance and reliever therapy and traditional therapies for treating asthma.

Pharmacogenomics enhances cardiometabolic disease management by personalizing medication based on genetic profiles, empowering pharmacists to optimize patient care.

Independent pharmacies navigate a transformative 2026, benefiting from increased PBM accountability and transparency, fostering a more stable operational landscape.

Inhaled Technosphere insulin revolutionizes diabetes management for children and pregnant women, addressing treatment adherence and psychological barriers effectively.

As lawmakers continue to deliberate on HR 7148, pharmacy law expert, Jesse Dresser, Esq, joined Drug Topics to discuss its provisions related to PBMs.

Pharmacists play a crucial role in managing complex medication regimens, ensuring safety and effectiveness for patients with behavioral health conditions.

Jari Becker, RPh, director of women’s health at Town & Country Compounding Pharmacy in Ramsey, New Jersey, shares how the pharmacy creates customized medications for patients all over the US.

Pharmacists enhance community health by providing vital services such as vaccinations and chronic disease management, despite facing reimbursement and recognition challenges.